World J Clin Cases. 2015 Feb 16;3(2):148-55. doi: 10.12998/wjcc.v3.i2.148.

Role of coronary physiology in the contemporary management of coronary artery disease.

World journal of clinical cases

Neil Ruparelia, Rajesh K Kharbanda

PMID: 25685761 PMCID: PMC4317608 DOI: 10.12998/wjcc.v3.i2.148

Abstract

Coronary artery disease (CAD) remains the leading cause of death worldwide with approximately 1 in 30 patients with stable CAD experiencing death or acute myocardial infarction each year. The presence and extent of resultant myocardial ischaemia has been shown to confer an increased risk of adverse outcomes. Whilst, optimal medical therapy (OMT) forms the cornerstone of the management of patients with stable CAD, a significant number of patients present with ischaemia refractory to OMT. Historically coronary angiography alone has been used to determine coronary lesion severity in both stable and acute settings. It is increasingly clear that this approach fails to accurately identify the haemodynamic significance of lesions; especially those that are visually "intermediate" in severity. Revascularisation based upon angiographic appearances alone may not reduce coronary events above OMT. Technological advances have enabled the measurement of physiological indices including the fractional flow reserve, the index of microcirculatory resistance and the coronary flow reserve. The integration of these parameters into the routine management of patients presenting to the cardiac catheterization laboratory with CAD represents a critical adjunctive tool in the optimal management of these patients by identifying patients that would most benefit from revascularisation and importantly also highlighting patients that would not gain benefit and therefore reducing the likelihood of adverse outcomes associated with coronary revascularisation. Furthermore, these techniques are applicable to a broad range of patients including those with left main stem disease, proximal coronary disease, diabetes mellitus, previous percutaneous coronary intervention and with previous coronary artery bypass grafting. This review will discuss current concepts relevant to coronary physiology assessment, its role in the management of both stable and acute patients and future applications.

Keywords: Coronary artery disease; Coronary flow reserve; Coronary physiology; Fractional flow reserve; Ischaemia

References

1. Clin Res Cardiol. 2014 Mar;103(3):191-201 - PubMed
2. Am Heart J. 1990 Jan;119(1):178-84 - PubMed
3. J Am Coll Cardiol. 2005 Aug 16;46(4):633-7 - PubMed
4. Am Heart J. 2013 Oct;166(4):662-668.e3 - PubMed
5. Circulation. 2001 Oct 23;104(17):2003-6 - PubMed
6. JACC Cardiovasc Interv. 2010 Dec;3(12):1274-81 - PubMed
7. Circulation. 2003 Jul 1;107(25):3129-32 - PubMed
8. J Am Coll Cardiol. 1983 Apr;1(4):994-1001 - PubMed
9. Eur Heart J. 2011 Apr;32(8):1012-24 - PubMed
10. J Am Coll Cardiol. 2011 Nov 1;58(19):1989-97 - PubMed
11. J Am Coll Cardiol. 2001 Mar 1;37(3):754-60 - PubMed
12. Circulation. 2006 Sep 19;114(12):1321-41 - PubMed
13. Circulation. 2001 Jul 10;104(2):157-62 - PubMed
14. Circulation. 1998 Feb 17;97(6):535-43 - PubMed
15. J Am Coll Cardiol. 2012 Jul 17;60(3):181-90 - PubMed
16. J Am Coll Cardiol. 2014 Apr 8;63(13):1253-61 - PubMed
17. Eur Heart J. 2014 Aug 1;35(29):1971-80 - PubMed
18. J Am Coll Cardiol. 1986 Mar;7(3):464-71 - PubMed
19. J Am Coll Cardiol. 2011 Mar 15;57(11):1280-8 - PubMed
20. J Am Coll Cardiol. 2010 Jul 13;56(3):177-84 - PubMed
21. JAMA. 2012 Sep 26;308(12 ):1237-45 - PubMed
22. JACC Cardiovasc Interv. 2010 Jul;3(7):715-22 - PubMed
23. J Am Coll Cardiol. 2008 Aug 19;52(8):636-43 - PubMed
24. J Am Coll Cardiol. 2012 Apr 10;59(15):1392-402 - PubMed
25. Lancet. 2011 Dec 10;378(9808):2013-20 - PubMed
26. J Am Coll Cardiol. 2007 May 29;49(21):2105-11 - PubMed
27. J Am Coll Cardiol. 1995 Jun;25(7):1522-8 - PubMed
28. Circulation. 1977 Feb;55(2):324-8 - PubMed
29. J Am Coll Cardiol. 2009 Sep 15;54(12):1072-84 - PubMed
30. Circ Cardiovasc Interv. 2012 Aug 1;5(4):515-22 - PubMed
31. Circulation. 1996 Oct 15;94(8):1842-9 - PubMed
32. Circulation. 1995 Oct 15;92 (8):2333-42 - PubMed
33. Circulation. 2001 May 29;103(21):2566-71 - PubMed
34. J Nucl Cardiol. 2006 Nov;13(6):768-78 - PubMed
35. J Am Coll Cardiol. 2011 Nov 29;58(23):2432-46 - PubMed
36. Circulation. 1994 May;89(5):2150-60 - PubMed
37. PLoS Med. 2006 Nov;3(11):e442 - PubMed
38. JAMA. 2007 Mar 21;297(11):1197-206 - PubMed
39. Circulation. 2002 Jun 25;105(25):2950-4 - PubMed
40. Lancet. 2010 Feb 27;375(9716):763-72 - PubMed
41. Circulation. 2009 Oct 13;120(15):1505-12 - PubMed
42. Circulation. 2003 Jun 17;107(23):2900-7 - PubMed
43. N Engl J Med. 1996 Jun 27;334(26):1703-8 - PubMed
44. Circ Cardiovasc Interv. 2012 Feb 1;5(1):103-8, S1-2 - PubMed
45. JACC Cardiovasc Imaging. 2012 Jul;5(7):715-24 - PubMed
46. Circulation. 1990 Apr;81(4):1319-30 - PubMed
47. N Engl J Med. 2009 Jan 15;360(3):213-24 - PubMed
48. J Am Coll Cardiol. 2003 Jul 2;42(1):64-70 - PubMed
49. Eur Heart J. 2006 Jul;27(13):1530-8 - PubMed
50. Circ Cardiovasc Interv. 2013 Apr;6(2):161-5 - PubMed
51. J Am Coll Cardiol. 2010 Jan 19;55(3):173-85 - PubMed
52. Coron Artery Dis. 2009 Aug;20(5):317-21 - PubMed
53. N Engl J Med. 2012 Sep 13;367(11):991-1001 - PubMed
54. Circulation. 1989 Oct;80(4):749-56 - PubMed
55. J Am Coll Cardiol. 2008 Feb 5;51(5):560-5 - PubMed
56. Am Heart J. 2013 Jul;166(1):110-8 - PubMed
57. J Cardiovasc Pharmacol. 1992;20 Suppl 11:S55-69 - PubMed
58. N Engl J Med. 2007 Apr 12;356(15):1503-16 - PubMed
59. Circulation. 2001 Jun 19;103(24):2928-34 - PubMed

Publication Types

• Journal Article
• Review